The neuropathological changes associated with normal brain aging

Histology and Histopathology

Volumn 11, Issue 4, 1996, Pages 1075-1088

  Hof, P R ^a   Giannakopoulos, P ^b   Bouras, C ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

aging; cerebral cortex; dementia; neurofibrillary tangle; senile plaque

Indexed keywords

AGING; ALZHEIMER DISEASE; BRAIN; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; REVIEW; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; FEMALE; HIPPOCAMPUS; HUMANS; MALE; NEURITES; NEUROFIBRILLARY TANGLES; NEURONS; REFERENCE VALUES;

EID: 0029952871     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Arriagada P.V., Growdon J.H., Hedley-White E.T. and Hyman B.T. (1992a). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639.
2. Arriagada P.V., Marzloff K. and Hyman B.T. (1992b). Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42, 1681-1688.
3. Ball M.J. (1977). Neuronal loss, neurofibrillary tangles and granulovascular degeneration in the hippocampus with ageing and dementia. Acta Neuropathol. 37, 111-118.
4. Berg L., McKeel D.W., Miller P., Baty J. and Morris J.C. (1993). Neuropathological indexes of Alzheimer's disease in demented and non-demented persons aged 80 years and older. Arch. Neurol. 50, 349-358.
5. Bierer L.M., Hof P.R., Purohit D.P., Carlin L., Schmeidler J., Davis K.L. and Perl D.P. (1995). Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol. 52, 81-88.
6. Bouras C., Hof P.R. and Morrison J.H. (1993). Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential ealry pathologic changes. Neurosci. Lett. 153, 131-135.
7. Bouras C., Hof P.R., Giannakopoulos P., Michel J.P. and Morrison J.H. (1994). Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb. Cortex 4, 138-150.
8. Braak H. and Braak E. (1985). On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol. 68, 325-332.
9. Braak H. and Braak E. (1990). Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathol. 80, 479-486
10. Braak H. and Braak E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.
11. Bramblett G.T., Trojanowski J.Q. and Lee V.M.Y. (1992). Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 protiens). Lab. Invest. 66, 212-222.
12. Brion J.P. (1990). Molecular pathology of Alzheimer amyloid and neurofibrillary tangles. Semin. Neurosci. 2, 89-100.
13. Buée-Scherrer V., Condamines O., Mourton-Gilels C., Jakes R., Goedert M., Pau B. and Delacourte A. (1996). AD2, a phosphorylation-dependent monoclonal antibody directed agaisnt tau proteins found in Alzheimer's disease. Mol. Brain Res. 39, 79-88.
14. Checler F. (1995). Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65, 1431-1444.
15. Crook T., Bartus R.T., Ferris S.H., Whitehouse P., Cohen G.D. and Gershon S. (1986). Age-associated memory impairment: proposed diagnostic criteria and measures of clinical changes - report of a National Institute of Mental Health work gorup. Dev. Neuropsychol. 2, 261-276.
16. Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., Masdeu J., Kawas C., Aronson M. and Wolfson L. (1988). Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38, 1682-1687.
17. Delacourte A., Flament S., Dibe E.M., Hublau P., Sablonnière B., Hémon B., Scherrer V. and Défossez A. (1990). Pathological proteins tau 64 and 69 are especifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease: demonstration with a panel of antibodies against tau proteins. Acta Neuropathol. 80, 111-117.
18. Delaère P., He Y., Fayet G., Duyckaerts C. and Hauw J.J. (1993). Beta A4 deposits are constant in the brain of the oldest old: an immunohistochemical study of 20 French centenarians. Neurobiol. Aging 14, 191-194.
19. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., BLau A.D., Davies P., Yen S.H. and Aronson M.K. (1991). Identification of normal and pathological aging in prospectively studied non-demented elderly humans. Neurobiol. Aging 13, 179-189.
20. Flament S., Delacourte A., Delaère P., Duyckaerts C. and Hau J.J. (1990). Correlation between microscopical changes and tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta Neuropathol. 80, 212-215.
21. Folstein M.F., Folstein S.E. and McHugh P.R. (1975). Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 12, 189-198.
22. Giannakopoulos P., Hof P.R., Surini M., Michel J.P. and Bouras C. (1993). Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians. Acta Neuropathol. 85, 602-610.
23. Giannakopoulos P., Hof P.R., Giannakopoulos A.S., Buée-Scherrer V., Delacourte A. and Bouras C. (1994). Dementia in the oldest-old: quantitative analysis of 12 cases from a psychiatric hospital. Dementia 5, 348-356.
24. Giannakopoulos P., Hof P.R., Giannakopoulos A.S., Hermann F.R. and Bouras C. (1995). Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch. Neurol. 52, 1150-1159.
25. Good P.P., Perl O.P., Bierer L.M. and Schmeidler J. (1992). Selective accumulation of aluminium and iron in the neurofibirllary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31, 286-292.
26. Gordon B. (1992). Memory systems and their disorders. In: Diseases of the nervous system. Clinical neurobiology. Asbury A.K., McKhann G.M. and McDonald W.I. (eds). W.B. Saunders, Philadelphia, pp 703-717.
27. Hauw J.J., Vignolo P., Duyckaerts C., Beck H., Forette F., Henry J.F., Laurent M., Piette F., Sachet A. and Berthaux P. (1986). Etude neuropathologique de 12 centenaires: la fréquence de la démence senile de type Alzheimer n'est pas particulièrement éleveŕe dans ce groupe de personne très agées. Rev. Neurol. 142, 107-115.
28. Heyman A., Wilkinson W.E., Hurwitz B.L., Helms M.J., Haynes C.S., Utley C.M. and Gwyther L.P. (1987). Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology 83, 170-178.
29. Hodges J.R., Salmon D.P. and Butters N. (1992). Semantic memory impairment in Alzheimer's disease: failure of access or degraded knowledge? Neuropsychologia 30, 301-314.
30. Hof P.R. and Morriosn J.H. (1990). Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J. Comp. Neurol. 301, 55-64.
31. Hof P.R. and Morrison J.H. (1991). Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp. Neurol. 111, 293-301.
32. Hof P.R. and Morrison J.H. (1994). The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. In: Alzheimer disease. Terry R.D., Katzman R. and Bick K.L. (eds). Raven Press, new York, pp 197-229.
33. Hof P.R., Cox K. and Morrison J.H. (1990). Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 301, 44-54.
34. Hof P.R., Cox K., Young W.G., Celio M.R., Rogers J. and Morrison J.H. (1991). Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 50, 451-462.
35. Hof P.R., Bierer L.M., Perl D.P., Delacourte A., Buée L., Bouras C. and Morrison J.H. (1992). Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia - Regional and laminar distribution of neurofibrillary tangles and senile plaques. Arch. Neurol. 49, 946-953.
36. Hof P.R., Nimchinsky E.A., Celio M.R., Bouras C. and Morrison J.H. (1993). Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci. Lett. 152, 145-149.
37. Hubbard B.M., Fenton G.W. and Andersen J.M. (1990). A quantitative histological study of early clinical and preclinical Alzheimer's disease. Neuropathol. Appl. Neurobiol. 16, 111-121.
38. Hughes C.P., Berg L., Danziger W.I., Coben L.A. and Martin R.L. (1982). A new clinical scale for the staging of dementia. Br. J. Psychiat. 140, 566-572.
39. Hyman B.T., Van Hoesen G.W. and Damasio A.R. (1990). Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 40, 1721-1730.
40. Iversen L.L., Mortishire-Smith R.J., Pollack S.J. and Shearman M.S. (1995). The toxicity in vitro of β-amyloid protein. Biochem. J. 311, 1-16.
41. Karasawa A. (1992). Changes in intellectual ability in normal human aging. Shinkei Kenkuo no Shinpo 29, 536-546.
42. Katzman R. and Terry R.D. (1983). Normal aging of the nervous system. In: The neurology of aging. Katzman R. and Terry R.D. (eds). Davis. Philadelphia, pp 15-50.
43. Katzman R., Terry R., DeTeresa R., Brown T., Davies P., Fuld P., Renbing X. and Peck A. (1988). Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23, 138-144.
44. Kim K.S., Miller D.L., Sapienza V.G., Chen C.C.J., Vai C., Grundke-Iqbal I., Curry J.R. and Wisniewski H.M. (1988). Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2, 121-130.
45. Koivisko K., Reinikainen K.J., Hänninen T., Vanhanen M., Helkala E.L., Mykkanen L., Laasko M., Pyörälä K. and Riekkinen P.J. (1995). Prevalence of age-associated memory impairment in a randomly selected population form eastern Finland. Neurology 45, 741-747.
46. Lewis D.A. Campbell M.J., Terry R.D. and Morrison J.H. (1987). Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J. Neurosci. 7, 1799-1808.
47. Masliah E. (1995). Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol. Histopathol. 10, 505-519.
48. Masliah E., Mallory M., Hansen L., DeTeresa R. and Terry R.D. (1993). Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43, 192-197.
49. Matsuo S.E., Shi R.W., Billingsley M.L., Van de Voorde A., O'Connor M., Trojanowski J.W. and Lee V.M.I. (1994). Biopsy-derived adult human brain tau is phosphorylated at many of the same site as Alzheimer's disease paired helical filament tau. Neuron 13, 989-1002.
50. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Grain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G. and Berg L. (1991). The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
51. Mizutani T. and Shimada H. (1990). Neuropathological aspects of centenarian brains: study of 24 autopsy cases. In: Psychogeriatrics-biomedical and social advances. Hasegawa K. and Homma A. (eds). Excerpta Medica. Tokyo, pp 128-133.
52. Mizutani T. and Shimada H. (1992). Neuropathological background of twenty-seven centenarian brains. J. Neurol. Sci. 108, 168-177.
53. Morris J.C., McKeel Jr. D.W., Storandt M., Rubin E.H., Price J.L., Grant E.A., Ball M.J. and Berg L. (1991). Very mild Alzheimer's disease: Informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 41, 469-478.
54. Mountjoy C.Q., Roth M., Evans N.J.R. and Evans H.M.(1983). Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol. Aging 4,1 -11.
55. Pearson R.C.A., Esiri M.M., Hiorns R.W., Wilcock G.K. and Powell T.P.S. (1985). Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci. USA 82, 4531-4534.
56. Permanne B., Buée L., David J.P., Fallet-Bianco C., DiMenza C. and Delacourte A. (1995). Quantitation of Alzheimer's amyloid peptide and identification of related amyloid proteins by dot-blot immunoassays. Brain Res. 685, 154-162.
57. Price J.L., Davis P.B., Morris J.C. and White D.L. (1991). The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging. 12, 295-312.
58. Shin R.W., Lee V.M.Y. and Trojanowski J.Q. (1995). Neurofibrillary pathology and aluminium in Alzheimer's disease. Histol. Histopathol. 10, 969-978.
59. Terry R.D. and Wisniewski H.M. (1970). The ultrastructure of the neurofibrillary tangle and the senile plaque, in: CIBA Foundaiton symposium on Alzheimer's disease and related conditions. Wolstenholme C.E.W. and O'Connor M. (eds). J&A Churchill. London, pp 145-155.
60. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A. and Katzman R. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580.
61. Tomlisson B.E. (1972). Morphological brain changes in non-demented old people. In: Aging of the nervous system. Van Praag H.M. and Kalverboer A.K. (eds). DeErvon-Bohn, New York, pp 44-55.
62. Tomlinson B.E., Blessed G. and Roth M. (1968). Observations on the brain of non-demented old people. J. Neurol. Sci. 7, 331-356.
63. Trojanowski J.Q., Schmidt M.L., Shin R.W., Bramblett G.T., Rao D. and Lee V.M.Y. (1993). Altered tau and neurofilament proteins in neurodegenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain. Pathol. 3, 45-54.
64. Ulrich J. (1985). Alzheimer changes in non-demented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann. Neurol. 17, 273-277.
65. Vallet P.G., Guntern R., Hof P.R., Golaz J., Delacourte A., Robakis N.K. and Bouras C. (1992). A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol. 83, 170-178.
66. Vermersch P., David J.P., Frigard B., Fallet-Bianco C., Wattez A., Petit H. and Delacourte A. (1995). Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 19, 1035-1047.
67. Vickers J.C., Delacourte A. and Morrispn J.H. (1992). Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res. 594, 273-278.
68. Vickers J.C., Biederer B.M., Marugg R.A., Buée-Scherrer V., Buée L., Delacourte A. and Morrison J.H. (1994). Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience 62, 1-13.
69. West M.J., Coleman P.D., Flood D.G. and Troncoso J.C. (1994). Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344, 769-772.
70. Zola-Morgan S., Squire U.R., Rempel N.L., Glower R.P. and Amaral D.G. (1992). Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J. Neurosci. 12, 2582-2596.